All Pathways
PediatricsEmergency

Pediatric Bacterial Meningitis (IDSA/NICE)

Pediatric Bacterial Meningitis (IDSA/NICE): Suspected Pediatric Bacterial Meningitis → Recognition & Initial Stabilization → LP Contraindicated? → Perfo...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Suspected Pediatric Bacterial Meningitis

    Child with fever, altered mental status, meningeal signs

    1. Action

      Recognition & Initial Stabilization

      Clinical features and immediate actions

      • CLINICAL FEATURES:
      • • Fever, headache, photophobia
      • • Neck stiffness (may be absent in infants)
      • • Altered mental status, lethargy, irritability
      • • Bulging fontanelle (infants)
      • • Petechial/purpuric rash (meningococcal)
      • STABILIZE: ABCs, IV access, vitals
      1. Decision

        LP Contraindicated?

        Can lumbar puncture be done safely?

        • CONTRAINDICATIONS to LP:
        • • Signs of raised ICP (papilledema, posturing)
        • • GCS <10 or rapidly deteriorating
        • • Focal neurologic signs
        • • Coagulopathy (platelets <50K, INR >1.5)
        • • Hemodynamic instability/shock
        • • Skin infection at LP site
        1. Action

          Perform Lumbar Puncture

          CSF analysis essential for diagnosis

          • CSF STUDIES:
          • • Cell count and differential
          • • Glucose and protein
          • • Gram stain and culture
          • • Consider: PCR (bacterial, viral), latex agglutination
          • BACTERIAL CSF typical:
          • • WBC >1000 (neutrophil predominant)
          • • Protein >100 mg/dL
          • • Glucose <40 mg/dL or CSF:serum ratio <0.4
          1. Action

            Empiric Antibiotic Therapy

            Age-based empiric coverage

            • AGE >1 MONTH:
            • • Ceftriaxone 100 mg/kg/day IV divided q12h (max 4g/day)
            • • + Vancomycin 60 mg/kg/day IV divided q6h (for resistant S. pneumoniae)
            • NEONATES (<1 month):
            • • Ampicillin 200-300 mg/kg/day + Cefotaxime (or gentamicin)
            • • Covers GBS, E. coli, Listeria
            • Duration: 7-21 days depending on organism
            1. Action

              Dexamethasone

              Give with or before first antibiotic dose

              • DEXAMETHASONE 0.15 mg/kg IV q6h x 2-4 days
              • Give BEFORE or WITH first antibiotic dose
              • Most beneficial for H. influenzae and S. pneumoniae
              • May reduce neurologic sequelae
              • Contraindicated in neonates (debated)
              1. Action

                Supportive Care & Monitoring

                ICU-level care often needed

                • Monitor for complications:
                • • Seizures (treat with lorazepam/levetiracetam)
                • • Cerebral edema (consider mannitol/hypertonic saline)
                • • SIADH (fluid restrict if hyponatremic)
                • • DIC (if meningococcal)
                • • Subdural effusion/empyema
                • Serial neuro exams
                • Repeat LP if not improving by 48-72 hours
                1. Outcome

                  Follow-Up

                  Post-treatment care

                  • Hearing evaluation before discharge
                  • Neurodevelopmental follow-up
                  • Vaccination review
                  • Contact prophylaxis for N. meningitidis exposure
        2. Action

          Empiric Antibiotics IMMEDIATELY

          Do NOT delay antibiotics for LP or imaging

          • DO NOT DELAY ANTIBIOTICS!
          • If LP contraindicated → give antibiotics first
          • Get blood cultures before antibiotics if possible
          • (but do not delay abx for cultures)

Guideline Source

IDSA Practice Guidelines for Bacterial Meningitis 2004 + NICE 2024

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Does not cover neonatal meningitis in detail
  • Local resistance patterns may vary
  • Does not address viral or fungal meningitis

Applicable Regions

USEU
Version 1Next review: 2027-01-11

Frequently Asked Questions

What is the Pediatric Bacterial Meningitis (IDSA/NICE)?

The Pediatric Bacterial Meningitis (IDSA/NICE) is a emergency clinical algorithm for Pediatrics. It provides a structured decision tree to guide clinical decision-making, based on IDSA Practice Guidelines for Bacterial Meningitis 2004 + NICE 2024.

What guideline is the Pediatric Bacterial Meningitis (IDSA/NICE) based on?

This algorithm is based on IDSA Practice Guidelines for Bacterial Meningitis 2004 + NICE 2024 (DOI: 10.1093/cid/cih430).

What are the limitations of the Pediatric Bacterial Meningitis (IDSA/NICE)?

Known limitations include: Does not cover neonatal meningitis in detail; Local resistance patterns may vary; Does not address viral or fungal meningitis. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Pediatric Bacterial Meningitis (IDSA/NICE) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free